SNORA53 and glioblastoma: Further validation by RT-qPCR revealed SMIM30, SNORA53 and LINC01354 were significantly upregulated and EFEMP2 markedly downregulated in 15 glioblastoma samples compared to 6 controls samples (Figure S2a).